In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy

Cancer Gene Therapy

Volumn 5, Issue 5, 1998, Pages 274-280

  Shirakawa, Toshiro ^a   Ko, Song Chu ^a   Gardner, Thomas A ^a   Cheon, Jun ^b   Miyamoto, Tadayuki ^a   Gotoh, Akinobu ^c   Chung, Leland W K ^a   Kao, Chinghai ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Korea University   (South Korea)

^c KOBE UNIVERSITY   (Japan)

Author keywords

Adenovirus; Osteocalcin promoter; Osteosarcoma; Pulmonary metastasis; Thymidine kinase; Toxic gene therapy

Indexed keywords

ACICLOVIR; OSTEOCALCIN; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DISEASE MODEL; EXPERIMENTAL NEOPLASM; GENE THERAPY; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUMOR; METASTASIS; METHODOLOGY; MORTALITY; MOUSE; OSTEOSARCOMA; PROMOTER REGION; RAT; SECRETION; SURVIVAL RATE;

ACYCLOVIR; ADENOVIRIDAE; ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; OSTEOCALCIN; OSTEOSARCOMA; PROMOTER REGIONS (GENETICS); RATS; SURVIVAL RATE; THYMIDINE KINASE;

EID: 0032151946     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cheon J, Ko SC, Gardner TA, et al. Chemogene therapy for osteosarcoma: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model. Cancer Gene Ther. 1997;4:359-365.
2. Bonnekoh B, Greenhalgh DA, Bundman DS, et al. Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J Invest Dermatol. 1995;104:313-317.
3. Eastham JA, Chen SH, Sehgal I, et al. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum Gene Ther. 1996;7:515-523.
4. Ko SC, Cheon J, Kao C, et al. Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models. Cancer Res. 1996;56:4614-4619.
5. Treat J, Kaiser LR, Sterman DH, et al. Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase I trial (BB-IND 6274). Hum Gene Ther. 1996;7:2047-2057.
6. Eck SL, Alavi JB, Alavi A, et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther. 1996;7: 1465-1482.
7. Lesoon-Wood LA, Kim WH, Kleinman HK, et al. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum Gene Ther. 1995;6:395-405.
8. Vile RG, Nelson JA, Casteleden S, et al. Systemic gene therapy of murine melanoma using tissue-specific expression of the HSVtk gene involves an immune component. Cancer Res. 1994;54:6228-6234.
9. Brand K, Arnold W, Bartels T, et al. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther. 1997;4:9-16.
10. O'Reilly R. NCCN Pediatric osteosarcoma practice guidelines: the National Comprehensive Cancer Network. Oncology. 1996;10:1799-1806.
11. Saeter G, Hoie J, Stenwig AE, et al. Systematic relapse of patients with osteogenic sarcoma: prognostic factors for long term survival. Cancer. 1995;75:1084-1093.
12. Naka T, Fukuda T, Shinohara N, et al. Osteosarcoma versus malignant fibrous histiocytoma of bone in patients older than 40 years: a clinicopathologic and immunohistochemical analysis with special reference to malignant fibrous histiocytoma-like osteosarcoma. Cancer. 1995;76:972-984.
13. Malawer MM, Link MP, Donaldson SS. Sarcomas of bone. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Company; 1993:1509-1566.
14. Ward W, Mikaelian K, Dorey F, et al. Pulmonary metastases of stage HB extremity osteosarcoma and subsequent pulmonary metastases. J Clin Oncol. 1994;12:1849-1858.
15. Ducy P, Karsenty G. Two distinct osteoblast-specific cisacting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 1995;15:1858-1869.
16. Zhang WW, Fang X, Branch CD, et al. Generation and identification of recombinant adenovirus by liposomemediated transfection and PCR analysis. Biotechniques. 1993;15:868-872.
17. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol. 1995;3:207-220.
18. Wilcoxon F. Individual comparisons by ranking methods. Biometrics Bull. 1945;1:80-83.
19. Zhu N, Liggitt D, Liu Y, et al. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 1993;261:209-211.
20. Thierry AR, Lunardi-Iskandar Y, Bryant JL, et al. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci USA. 1995;92:9742-9746.
21. Philip R, Liggitt D, Philip M, et al. In vivo gene delivery: efficient transfection of T lymphocytes in adult mice. J Biol Chem. 1993;268:16087-16090.
22. Donahue HJ, McLeod KJ, Rubin CT, et al. Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J Bone Miner Res. 1995;10:881-889.
23. Weksler B, Lenert J, Ng B, et al. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg. 1994;107:50-54.